FDA 483 - BPC Plasma, Inc. - October 21, 2020

An FDA inspection of BPC Plasma, Inc. in Youngstown, OH, revealed a significant issue regarding the suitability of blood and blood component donations. The firm failed to adequately determine donor suitability due to incomplete medication lists and travel history information on donor questionnaires. This indicates a moderate severity finding related to donor screening processes.